glycylglutamine has been researched along with Cancer of Colon in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gilbert, HJ; Hirst, BH; Simmons, NL; Thwaites, DT; Walker, D | 1 |
| Dietl, KH; Goeters, C; Kuhmann, M; Lange, V; Lawin, P; Mertes, N | 1 |
1 trial(s) available for glycylglutamine and Cancer of Colon
| Article | Year |
|---|---|
[Safety and tolerance of a new dipeptide-containing amino acid solution DP-Gln 20 versus a conventional amino acid solution Vamin 18EF in patients after elective colon surgery].
Topics: Adolescent; Adult; Aged; Amino Acids; Colectomy; Colonic Neoplasms; Dipeptides; Electrolytes; Female; Glucose; Humans; Male; Middle Aged; Parenteral Nutrition Solutions; Parenteral Nutrition, Total; Postoperative Care; Prospective Studies; Solutions | 1994 |
1 other study(ies) available for glycylglutamine and Cancer of Colon
| Article | Year |
|---|---|
Substrate upregulation of the human small intestinal peptide transporter, hPepT1.
Topics: Adenocarcinoma; Amino Acid Substitution; Biological Transport; Carrier Proteins; Cell Line; Cell Membrane; Cloning, Molecular; Colonic Neoplasms; Dipeptides; Gene Expression Regulation; Humans; Immunoblotting; Intestine, Small; Kinetics; Peptide Transporter 1; Recombinant Proteins; RNA, Messenger; Symporters; Transcription, Genetic | 1998 |